VITREORETINAL OUTCOMES FOLLOWING SECONDARY INTRAOCULAR LENS IMPLANTATION WITH PARS PLANA VITRECTOMY
Gabriel T Kaufmann1, Omesh Gupta2, Julia Yu2
1Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.
Retina (Philadelphia, Pa.)
|July 24, 2024
Summary
Secondary intraocular lens (IOL) implantation techniques showed similar rates of retinal detachment and tears. Careful vitreoretinal management is crucial due to common intraoperative complications like endolaser use and retinal tears.
Area of Science:
- Ophthalmology
- Retina Surgery
Background:
- A retrospective cohort study analyzed 561 adult patients who underwent secondary intraocular lens (IOL) implantation.
- The study period was from April 2015 to December 2020, involving vitreoretinal surgeons at a single institution.
Purpose of the Study:
- To compare the outcomes of different secondary intraocular lens (IOL) implantation techniques.
- To assess primary outcomes including postoperative retinal tears and rhegmatogenous retinal detachment.
- To evaluate secondary outcomes such as intraoperative endolaser use, intraoperative retinal tears, and the need for further IOL surgery.
Main Methods:
- Retrospective cohort study design.
- Inclusion of 561 adult patients undergoing secondary IOL implantation.
- Assessment of patient history, intraoperative/postoperative complications, and outcomes stratified by IOL type: anterior chamber IOL, scleral sutured IOL, scleral fixated IOL, and sulcus IOL.
Main Results:
- The incidence of intraoperative retinal tears was 7.3%, with no significant difference between techniques.
- Intraoperative endolaser use was observed in 17.5% of cases, also not significantly different across techniques.
- Postoperative rhegmatogenous retinal detachment rates were similar across all techniques (4.6% overall), with no statistically significant variations.
- Repeat IOL surgery rates trended higher for sulcus lenses (14.3%) compared to other methods.
Conclusions:
- Intraoperative endolaser use and retinal tears are frequent occurrences in secondary IOL surgery.
- These findings highlight the critical need for meticulous vitreoretinal management in patients undergoing secondary IOL implantation.


